{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:15:48Z","timestamp":1777518948634,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102346","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T20:44:18Z","timestamp":1745959458000},"page":"102346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The crossroads of Leber hereditary optic neuropathy and autosomal dominant optic Atrophy: Clinical profiles of patients with coexisting pathogenic genetic variants"],"prefix":"10.1016","volume":"38","author":[{"given":"Mohammed A.","family":"Halawani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0213-821X","authenticated-orcid":false,"given":"Nooran O.","family":"Badeeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2025.102346_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajoc.2025.102346_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","article-title":"Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders","volume":"1787","author":"Carelli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajoc.2025.102346_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajoc.2025.102346_bib4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/jmedgenet-2013-101774","article-title":"A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network","volume":"50","author":"Grau","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5301\/ejo.5000055","article-title":"Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe","volume":"22","author":"Mascialino","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejhg.5201828","article-title":"Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland","volume":"15","author":"Puomila","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of Leber hereditary optic neuropathy in the North East of England","volume":"72","author":"Yu-Wai-Man","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11940-010-0100-y","article-title":"Leber's hereditary optic neuropathy","volume":"13","author":"Sadun","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ajoc.2025.102346_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042242","article-title":"Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber's hereditary optic neuropathy","volume":"7","author":"Achilli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2025.102346_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2018.09.014","article-title":"The 7q11.23 protein DNAJC30 interacts with ATP synthase and links mitochondria to brain development","volume":"175","author":"Tebbenkamp","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ajoc.2025.102346_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mito.2016.10.002","article-title":"Characterization of a Leber's hereditary optic neuropathy (LHON) family harboring two primary LHON mutations m.11778G>A and m.14484T>C of the mitochondrial DNA","volume":"36","author":"Catarino","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ajoc.2025.102346_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/aes.2020.02.04","article-title":"Application of optical coherence tomography in hereditary, toxic and metabolic optic neuropathies","volume":"5","author":"EnrightG","year":"2020","journal-title":"Annals Eye Sci"},{"key":"10.1016\/j.ajoc.2025.102346_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2020.00024","article-title":"Novel MT-ND gene variants causing adult-onset mitochondrial disease and isolated complex I deficiency","volume":"11","author":"Ng","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib15","first-page":"13","article-title":"Further advances in the diagnosis and treatment of Leber's hereditary optic neuropathy - a review","volume":"66","author":"T\u0103b\u0103caruH","year":"2022","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0420.1996.tb00672.x","article-title":"Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects","volume":"74","author":"Kjer","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajoc.2025.102346_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3109\/08820538.2013.825296","article-title":"Autosomal dominant hereditary optic neuropathy (ADOA): a review of the genetics and clinical manifestations of ADOA and ADOA+","volume":"28","author":"Skidd","year":"2013","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","article-title":"The prevalence and natural history of dominant optic atrophy due to OPA1 mutations","volume":"117","author":"Yu-Wai-Man","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102346_bib19","first-page":"1715","article-title":"A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy","volume":"43","author":"Thiselton","year":"2002","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2025.102346_bib20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/hmg\/10.13.1369","article-title":"Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy","volume":"10","author":"Toomes","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib21","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","volume":"30","author":"Ferr\u00e9","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajoc.2025.102346_bib22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0161-6420(01)00696-0","article-title":"Disc excavation in dominant optic atrophy: differentiation from normal tension glaucoma","volume":"108","author":"Fournier","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102346_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/bjo.87.1.48","article-title":"Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy","volume":"87","author":"Votruba","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","article-title":"Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy","volume":"112","author":"Barboni","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102346_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajoc.2025.102346_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.optom.2016.09.003","article-title":"A review of mitochondrial optic neuropathies: from inherited to acquired forms","volume":"10","author":"Pilz","year":"2017","journal-title":"J Opt"},{"key":"10.1016\/j.ajoc.2025.102346_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/brain\/awr330","article-title":"Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity","volume":"135","author":"Williams","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2025.102346_bib28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/ddm079","article-title":"Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function","volume":"16","author":"Davies","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib29","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/brain\/awq218","article-title":"Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy","volume":"133","author":"Williams","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2025.102346_bib30","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1056\/NEJM198905183202002","article-title":"A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy","volume":"320","author":"Singh","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2025.102346_bib31","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ajoc.2025.102346_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.116.3.351","article-title":"Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy","volume":"116","author":"Votruba","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ajoc.2025.102346_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ncl.2016.08.004","article-title":"Update on idiopathic intracranial hypertension","volume":"35","author":"Wall","year":"2017","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ajoc.2025.102346_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/138920211794520150","article-title":"LHON: mitochondrial mutations and more","volume":"12","author":"Kirches","year":"2011","journal-title":"Curr Genom"},{"key":"10.1016\/j.ajoc.2025.102346_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138267","article-title":"Impaired complex I repair causes recessive Leber's hereditary optic neuropathy","volume":"131","author":"Stenton","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ajoc.2025.102346_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2025.102346_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmg.2007.054270","article-title":"Inherited mitochondrial optic neuropathies","volume":"46","author":"Yu-Wai-Man","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mito.2017.07.004","article-title":"Incomplete penetrance in mitochondrial optic neuropathies","volume":"36","author":"Caporali","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ajoc.2025.102346_bib40","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1093\/brain\/awv339","article-title":"Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion","volume":"139","author":"Carelli","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2025.102346_bib41","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1167\/iovs.16-20389","article-title":"High mitochondrial DNA copy number is a protective factor from vision loss in heteroplasmic Leber's hereditary optic neuropathy (LHON)","volume":"58","author":"Bianco","year":"2017","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2025.102346_bib42","article-title":"Intrafamilial \u201cDOA\u2010plus\u201d phenotype variability related to different OMI\/HTRA2 expression","volume":"182","author":"Napolitano","year":"2019","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajoc.2025.102346_bib43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archopht.1993.01090040087038","article-title":"Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation","volume":"111","author":"Johns","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib44","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/bjophthalmol-2016-310072","article-title":"Childhood-onset Leber hereditary optic neuropathy","volume":"101","author":"Majander","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/WNO.0000000000000830","article-title":"Clinical and optic disc characteristics of patients showing visual recovery in Leber hereditary optic neuropathy","volume":"40","author":"Moon","year":"2020","journal-title":"J Neuro Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16344","article-title":"Co-occurrence of glial fibrillary acidic protein astrocytopathy in a patient with Leber's hereditary optic neuropathy due to mutations","volume":"31","author":"Giannoccaro","year":"2024","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ajoc.2025.102346_bib47","first-page":"64","article-title":"Hereditary optic neuropathies: an updated review","volume":"2","author":"Lee","year":"2024","journal-title":"J Clin Transl Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib48","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1167\/iovs.07-0024","article-title":"Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations","volume":"48","author":"Ito","year":"2007","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2025.102346_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajoc.2025.102346_bib50","series-title":"Pediatric Cancer Genetics","first-page":"47","article-title":"Chapter 5 - genetic testing techniques","author":"Korf","year":"2018"},{"key":"10.1016\/j.ajoc.2025.102346_bib51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.critrevonc.2015.06.007","article-title":"Understanding next generation sequencing in oncology: a guide for oncologists","volume":"96","author":"Moorcraft","year":"2015","journal-title":"Crit Rev Oncol-Hematol"},{"key":"10.1016\/j.ajoc.2025.102346_bib52","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018763682","article-title":"Whole-exome sequencing improves genetic testing accuracy in pulmonary artery hypertension","volume":"8","author":"Zeng","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.ajoc.2025.102346_bib53","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","article-title":"Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography","volume":"117","author":"Barboni","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102346_bib54","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.ophtha.2011.02.027","article-title":"Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age","volume":"118","author":"Barboni","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102346_bib55","article-title":"Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial","volume":"5","author":"Yu-Wai-Man","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajoc.2025.102346_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber's hereditary optic neuropathy","volume":"134","author":"Carelli","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2025.102346_bib57","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2025.102346_bib58","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/acn3.51026","article-title":"Idebenone increases chance of stabilization\/recovery of visual acuity in OPA1-dominant optic atrophy","volume":"7","author":"Romagnoli","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ajoc.2025.102346_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.ajoc.2025.102346_bib60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40265-016-0574-3","article-title":"Idebenone: a review in Leber's hereditary optic neuropathy","volume":"76","author":"Lyseng-Williamson","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ajoc.2025.102346_bib61","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00417-019-04444-6","article-title":"Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset","volume":"257","author":"Pemp","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib62","article-title":"Long-term efficacy and safety of idebenone in patients with LHON in the chronic phase: results from the LEROS study","volume":"63","author":"Ll\u00f2ria","year":"2022","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2025.102346_bib63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","article-title":"International consensus statement on the clinical and therapeutic management of Leber hereditary optic neuropathy","volume":"37","author":"Carelli","year":"2017","journal-title":"J Neuro Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102346_bib64","article-title":"New avenues for therapy in mitochondrial optic neuropathies","volume":"2","author":"Ng","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ajoc.2025.102346_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.omtn.2021.08.015","article-title":"CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs","volume":"26","author":"Sladen","year":"2021","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:28:43Z","timestamp":1760146123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":65,"alternative-id":["S2451993625000994"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102346","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The crossroads of Leber hereditary optic neuropathy and autosomal dominant optic Atrophy: Clinical profiles of patients with coexisting pathogenic genetic variants","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102346"}}